![]() ![]() The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. For more information, please visit Safe Harbor Statement Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our Mission is to enable our customers to make the world healthier, cleaner and safer. is the world leader in serving science, with annual revenue over $40 billion. To access the presentation materials from today’s investor event, visit the Company’s investor relations website at. and its capital deployment approach creates tremendous value, positioning the company to deliver Core organic revenue growth of 7% to 9% and mid-teens adjusted EPS growth over the long-term. Thermo Fisher’s proven growth strategy drives share gain. Consistently delivering exceptional financial results with an outstanding long-term outlook.More details can be found in the most recent CSR Report. The company continues to differentiate itself by advancing its ESG strategy including innovating for a cleaner planet, investing in colleagues and communities, and driving impact and accountability. Mission-led ESG strategy drives competitive differentiation.PPI delivers competitive advantage, enables successful integration of acquisitions and drives differentiated financial performance. PPI is at the core of Thermo Fisher’s culture, with a focus on continuous improvement that drives quality, productivity and customer allegiance and engages every colleague to find a better way, everyday. Practical Process Improvement PPI Business System enables outstanding execution.Our proven M&A approach leverages rigorous selection criteria, disciplined decision-making and a strong integration process to better serve our customers and create value for our shareholders. Thermo Fisher has a disciplined capital deployment strategy which is a combination of strategic M&A and returning capital to shareholders. Proven capital deployment approach creates tremendous value.Thermo Fisher’s high-impact innovation, trusted partner status with industry-leading products, services and expertise, and an unparalleled commercial engine continue to uniquely position the company to drive meaningful share gain over the long-term. Proven growth strategy drives share gain.Our businesses have an outstanding track record of value creation and a bright future. Our industry-leading businesses are essential to the work our customers do and enable their success by accelerating their innovation and enhancing their productivity. Leading businesses offer best-in-class products and services.Thermo Fisher is the leader serving an attractive $240 billion market with long-term market growth of 4% to 6%. Industry leadership in attractive and resilient end markets.“As an incredibly well-positioned industry leader, we will continue to advance scientific discovery through our Mission to enable our customers to make the world healthier, cleaner and safer.”Ĭasper continued, “Our proven growth strategy and capital deployment approach, powered by our PPI Business System, create tremendous value for all stakeholders and position the company for a very bright future.”Īt today’s event, Thermo Fisher Scientific highlighted: Casper, chairman, president and chief executive officer. “Science is advancing at a rapid rate and we continue to bring high-impact innovation, and unique insights to differentiate Thermo Fisher as the trusted partner to our customers,” said Marc N. ![]() (NYSE: TMO), the world leader in serving science, hosted its 2023 Investor Day today and provided an in-depth review of the Company’s proven growth strategy and its industry-leading businesses: Life Science Solutions, Analytical Instruments, Specialty Diagnostics and Laboratory Products and Biopharma Services. WALTHAM, Mass.-( BUSINESS WIRE)-Thermo Fisher Scientific Inc. ![]()
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |